Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L M Metz

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
Neurology|December 22, 1999
Gastric tolerance of high-dose pulse oral prednisone in multiple sclerosisL M Metz, D Sabuda, R J Hilsden, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|November 10, 2010
Corpus callosum volume and interhemispheric transfer in multiple sclerosisL N Brown, Y Zhang, J R Mitchell, et al.
Neurology|July 20, 2007
Experimental models of neuroprotection relevant to multiple sclerosisV W Yong, F Giuliani, M Xue, et al.
Neurology|September 29, 2004
The bioavailability of IV methylprednisolone and oral prednisone in multiple sclerosisS A Morrow, C A Stoian, J Dmitrovic, et al.
Neurology|December 10, 2003
Major depression in multiple sclerosis: a population-based perspectiveS B Patten, C A Beck, J V A Williams, et al.
European Journal of Neurology|January 10, 2018
Global transcriptome profiling of mild relapsing-remitting versus primary progressive multiple sclerosisM W Koch, Y Ilnytskyy, A Golubov, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|August 30, 2003
Cannabis use as described by people with multiple sclerosisS A Page, M J Verhoef, R A Stebbins, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 1, 2007
Deep grey matter "black T2" on 3 tesla magnetic resonance imaging correlates with disability in multiple sclerosisY Zhang, R K Zabad, X Wei, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 9, 2002
Cytokine production in T lymphocyte-microglia interaction is attenuated by glatiramer acetate: a mechanism for therapeutic efficacy in multiple sclerosisS Chabot, F P Yong, D M Le, et al.
Annals of Neurology|May 19, 2001
Diminished adenosine A1 receptor expression on macrophages in brain and blood of patients with multiple sclerosisJ B Johnston, C Silva, G Gonzalez, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Neurology|December 22, 1999
Gastric tolerance of high-dose pulse oral prednisone in multiple sclerosisL M Metz, D Sabuda, R J Hilsden, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|November 10, 2010
Corpus callosum volume and interhemispheric transfer in multiple sclerosisL N Brown, Y Zhang, J R Mitchell, et al.
Neurology|July 20, 2007
Experimental models of neuroprotection relevant to multiple sclerosisV W Yong, F Giuliani, M Xue, et al.
Neurology|September 29, 2004
The bioavailability of IV methylprednisolone and oral prednisone in multiple sclerosisS A Morrow, C A Stoian, J Dmitrovic, et al.
Neurology|December 10, 2003
Major depression in multiple sclerosis: a population-based perspectiveS B Patten, C A Beck, J V A Williams, et al.
European Journal of Neurology|January 10, 2018
Global transcriptome profiling of mild relapsing-remitting versus primary progressive multiple sclerosisM W Koch, Y Ilnytskyy, A Golubov, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|August 30, 2003
Cannabis use as described by people with multiple sclerosisS A Page, M J Verhoef, R A Stebbins, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 1, 2007
Deep grey matter "black T2" on 3 tesla magnetic resonance imaging correlates with disability in multiple sclerosisY Zhang, R K Zabad, X Wei, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 9, 2002
Cytokine production in T lymphocyte-microglia interaction is attenuated by glatiramer acetate: a mechanism for therapeutic efficacy in multiple sclerosisS Chabot, F P Yong, D M Le, et al.
Annals of Neurology|May 19, 2001
Diminished adenosine A1 receptor expression on macrophages in brain and blood of patients with multiple sclerosisJ B Johnston, C Silva, G Gonzalez, et al.
Pageof 4